LIGAND PHARMACEUTICALS INCORPORATED Debt Instrument, Convertible, If-converted Value in Excess of Principal
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Debt Instrument, Convertible, If-converted Value in Excess of Principal of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal · last filed 2019-11-08
- LIGAND PHARMACEUTICALS INCORPORATED debt instrument, convertible, if-converted value in excess of principal for the quarter ending 2019-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED debt instrument, convertible, if-converted value in excess of principal for the quarter ending 2018-09-30 was $0.00.
| Period end | Debt Instrument, Convertible, If-converted Value in Excess of Principal 3 month | Debt Instrument, Convertible, If-converted Value in Excess of Principal 6 month | Debt Instrument, Convertible, If-converted Value in Excess of Principal 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $31.57M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $31.57M 10-Q · filed 2019-08-08 |